Results 241 to 250 of about 178,684 (361)
Evaluation of cardiac strain parameters in pregnant women with and without iron deficiency anemia: a prospective case control study. [PDF]
Özbebek YE +6 more
europepmc +1 more source
ABSTRACT Objectives Although Advancements in the Treatment of Hemoglobinopathies have Considerably Increased Life Expectancy, Hormonal and Pubertal Development Have Been Continuously Affected by Complications From Transfusion‐Related Iron Overload and Cytotoxic Therapies.
J. Dülberg +20 more
wiley +1 more source
Correction to "Iron-Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus". [PDF]
europepmc +1 more source
Efficacy of Ferrous Sulphate in the Management of Iron Deficiency Anemia in Children. [PDF]
Siraj K +9 more
europepmc +1 more source
Genetic risk factor identification for common epilepsies guided by integrative omics data analysis
Abstract Objective Genetic generalized epilepsies (GGEs) comprise the most common genetically determined epilepsy syndromes, following a complex mode of inheritance. Although many important common and rare genetic factors causing or contributing to these epilepsies have been identified in the past decades, many features of the genetic architecture are ...
Ashwini Mushunuri +9 more
wiley +1 more source
Molecular detection of pathogens in an equine fever diagnostic panel: 2019–2023
Abstract Background A common diagnostic approach for febrile horses is to test for a panel of potential pathogens. Panels are curated by expert opinion and vary between diagnostic laboratories. Objectives To report the results of a newly developed equine fever diagnostic panel (EFDP) between 2019 and 2023 and evaluate the frequency of positive results.
Toby L. Pinn‐Woodcock +3 more
wiley +1 more source
Unmasking iron deficiency and iron deficiency anemia in Saudi Arabia: Data from a large private sector lab. [PDF]
Radhwi OO +3 more
europepmc +1 more source
ABSTRACT Background The Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Haemophilia (ATHN 7) monitors use of contemporary haemophilia therapies, including emicizumab, a bispecific antibody substituting for activated factor (F)VIII in people with haemophilia A (HA).
Tyler W. Buckner +12 more
wiley +1 more source

